Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
MannKind Corp (MNKD)  
$4.23 0.05 (1.2%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 232,600,000
Market Cap: 983.90(M)
Last Volume: 3,439,679 Avg Vol: 3,430,080
52 Week Range: $3.25 - $5.45
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MannKind is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Co.'s primary product, Afrezza (insulin human) Inhalation Powder, is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. Co. collaborates with United Therapeutics to develop an inhaled formulation of treprostinil known as Tyvaso DPI.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 13,519
Total Buy Value $0 $0 $0 $39,611
Total People Bought 0 0 0 4
Total Buy Transactions 0 0 0 4
Total Shares Sold 0 210,482 798,860 830,475
Total Sell Value $0 $844,428 $3,571,716 $3,709,212
Total People Sold 0 1 3 4
Total Sell Transactions 0 3 18 22
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 427
  Page 1 of 18  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sabella Lauren M EVP Chief Operating Officer   •       –      –    2024-03-27 4 D $4.63 $79,099 D/D (17,084) 246,351     -
   Sabella Lauren M EVP Chief Operating Officer   •       –      –    2024-02-04 4 A $3.27 $49,998 D/D 15,290 263,435     -
   Blank Burkhard EVP Chief Medical Officer   •       –      –    2024-02-04 4 A $3.27 $499,999 D/D 152,905 367,905     -
   Consiglio Ronald J Director   –       •      –    2024-02-04 4 A $3.27 $81,750 D/D 25,000 545,997     -
   Kay Sabrina Director   –       •      –    2024-02-04 4 A $3.27 $349,998 D/D 107,033 265,600     -
   Hooper Anthony C Director   –       •      –    2024-02-04 4 A $3.27 $130,800 D/D 40,000 176,153     -
   Castagna Michael Chief Executive Officer   •       •      –    2024-02-04 4 A $3.27 $100,000 D/D 30,581 2,184,090     -
   Tross Stuart A Chief People & Workpl Officer   •       –      –    2024-02-04 4 A $3.27 $49,998 D/D 15,290 1,024,732     -
   Sabella Lauren M EVP Chief Operating Officer   •       –      –    2023-12-31 4 A $3.09 $2,197 D/D 711 248,145     -
   Blank Burkhard EVP Chief Medical Officer   •       –      –    2023-12-31 4 A $3.09 $15,450 D/D 5,000 215,000     -
   Castagna Michael Chief Executive Officer   •       •      –    2023-12-31 4 A $3.09 $646 D/D 209 2,153,509     -
   Tross Stuart A Chief People & Workpl Officer   •       –      –    2023-12-31 4 A $3.09 $3,109 D/D 1,006 1,009,442     -
   Castagna Michael Chief Executive Officer   •       •      –    2023-12-15 4 AS $4.00 $361,928 D/D (90,482) 2,148,665 6%     
   Castagna Michael Chief Executive Officer   •       •      –    2023-12-14 4 AS $4.00 $440,000 D/D (110,000) 2,239,147 5%     
   Castagna Michael Chief Executive Officer   •       •      –    2023-11-01 4 AS $4.25 $42,500 D/D (10,000) 2,349,147 14%     
   Singh Sanjay R EVP Technical Operations   •       –      –    2023-10-31 4 D $4.29 $73,235 D/D (17,071) 270,179     -
   Castagna Michael Chief Executive Officer   •       •      –    2023-10-02 4 AS $4.61 $46,100 D/D (10,000) 2,359,147 -13%     
   Castagna Michael Chief Executive Officer   •       •      –    2023-09-05 4 AS $4.91 $328,440 D/D (66,892) 2,369,147 -25%     
   Castagna Michael Chief Executive Officer   •       •      –    2023-09-01 4 AS $4.61 $46,100 D/D (10,000) 2,436,039 -25%     
   Thomson David EVP Genl Counsel & Secretary   •       –      –    2023-08-28 4 AS $4.78 $38,738 D/D (8,100) 798,835 -24%     
   Binder Steven B. Chief Financial Officer   •       –      –    2023-08-27 4 D $4.72 $95,948 D/D (20,328) 856,134     -
   Thomson David EVP Genl Counsel & Secretary   •       –      –    2023-08-27 4 D $4.72 $95,948 D/D (20,328) 806,935     -
   Castagna Michael Chief Executive Officer   •       •      –    2023-08-27 4 D $4.72 $239,285 D/D (50,696) 2,446,039     -
   Tross Stuart A Chief People & Workpl Officer   •       –      –    2023-08-27 4 D $4.72 $95,948 D/D (20,328) 1,004,424     -
   Castagna Michael Chief Executive Officer   •       •      –    2023-08-01 4 AS $4.57 $45,686 D/D (10,000) 2,496,735 -18%     
  427 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 18
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us